Amyris Upgraded to “Market Perform” by Cowen and Company (AMRS)
Amyris (NASDAQ:AMRS) was upgraded by research analysts at Cowen and Company to a “market perform” rating in a report released on Wednesday, Analyst Ratings Net reports.
Shares of Amyris (NASDAQ:AMRS) opened at 3.60 on Wednesday. Amyris has a one year low of $2.17 and a one year high of $6.11. The stock’s 50-day moving average is $4.11 and its 200-day moving average is $3.12. The company’s market cap is $274.6 million.
Amyris (NASDAQ:AMRS) last released its earnings data on Tuesday, February 25th. The company reported ($0.26) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.24) by $0.02. Analysts expect that Amyris will post $-1.21 EPS for the current fiscal year.
Amyris, Inc, formerly Amyris Biotechnologies, Inc develops and provides renewable compounds for a variety of markets.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.